AR090474A1 - Compuestos de tetrahidropirrolotiazina - Google Patents
Compuestos de tetrahidropirrolotiazinaInfo
- Publication number
- AR090474A1 AR090474A1 ARP130100947A ARP130100947A AR090474A1 AR 090474 A1 AR090474 A1 AR 090474A1 AR P130100947 A ARP130100947 A AR P130100947A AR P130100947 A ARP130100947 A AR P130100947A AR 090474 A1 AR090474 A1 AR 090474A1
- Authority
- AR
- Argentina
- Prior art keywords
- tetrahydropirrolotiazine
- compounds
- formula
- ch2oh
- och3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Composiciones farmacéuticas. Reivindicación 1: Un compuestos de la fórmula (1) caracterizado porque A se selecciona del grupo que consiste de las formulas (2), (3), (4) y (5); R¹ es H o F; R² es H, -CH₂OH, alquilo C₁₋₃, o un resto de fórmula (6) ó (7); R³ es H, F, o CN; R⁴ es H, F o CN; y R⁵ es H, -CH₃, o -OCH₃; o una sal del mismo farmacéuticamente aceptable.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261619460P | 2012-04-03 | 2012-04-03 | |
| US201261700960P | 2012-09-14 | 2012-09-14 | |
| US201361758798P | 2013-01-31 | 2013-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090474A1 true AR090474A1 (es) | 2014-11-12 |
Family
ID=48083661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100947A AR090474A1 (es) | 2012-04-03 | 2013-03-22 | Compuestos de tetrahidropirrolotiazina |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US8629270B2 (es) |
| EP (1) | EP2836495B1 (es) |
| JP (1) | JP6067099B2 (es) |
| CN (1) | CN104185635B (es) |
| AR (1) | AR090474A1 (es) |
| CA (1) | CA2866201C (es) |
| CY (1) | CY1117688T1 (es) |
| DK (1) | DK2836495T3 (es) |
| ES (1) | ES2584827T3 (es) |
| HR (1) | HRP20160674T1 (es) |
| HU (1) | HUE030097T2 (es) |
| JO (1) | JO3143B1 (es) |
| ME (1) | ME02404B (es) |
| PL (1) | PL2836495T3 (es) |
| PT (1) | PT2836495T (es) |
| RS (1) | RS54899B1 (es) |
| SI (1) | SI2836495T1 (es) |
| TW (1) | TWI572610B (es) |
| WO (1) | WO2013151832A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2711655C (en) | 2008-01-18 | 2013-03-05 | Eisai R&D Management Co., Ltd. | Condensed aminodihydrothiazine derivative |
| EP2912041B1 (en) | 2012-10-26 | 2016-12-14 | Eli Lilly and Company | Tetrahydropyrrolothiazine derivatives as bace inhibitors |
| TWI593692B (zh) * | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
| TWI684452B (zh) | 2014-03-14 | 2020-02-11 | 美國禮來大藥廠 | 胺基噻嗪化合物 |
| TWI570127B (zh) | 2014-09-15 | 2017-02-11 | 美國禮來大藥廠 | 結晶型N-[3-[(4aR,7aS)-2-胺基-6-(5-氟嘧啶-2-基)-4,4a,5,7-四氫吡咯并[3,4-d][1,3]噻嗪-7a-基]-4-氟-苯基]-5-甲氧基-吡嗪-2-甲醯胺、其用途及醫藥組合物 |
| EP3497105A1 (en) * | 2016-08-11 | 2019-06-19 | Eli Lilly And Company | Aminothiazines and their use as bace1 inhibitors |
| TWI726329B (zh) | 2018-06-22 | 2021-05-01 | 美商美國禮來大藥廠 | 2,3-二氫呋喃并[2,3-b]吡啶化合物 |
| CN111184725B (zh) * | 2020-02-27 | 2020-12-01 | 慈溪市人民医院医疗健康集团(慈溪市人民医院) | 一种防治脑梗塞的药物制剂及其制备方法 |
| CN111675659B (zh) * | 2020-06-16 | 2022-03-11 | 阿里生物新材料（常州）有限公司 | 一种（5-氟嘧啶-4-基）甲醇的合成方法 |
| CN112263583B (zh) * | 2020-11-23 | 2021-10-22 | 诸城市精神卫生中心 | 一种治疗帕金森疾病的药物及其制备方法 |
| CN113666878A (zh) * | 2021-08-27 | 2021-11-19 | 宁夏常晟药业有限公司 | 一种5-溴-2-氯嘧啶-4-羧酸甲酯的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI332005B (en) | 2005-06-14 | 2010-10-21 | Schering Corp | Aspartyl protease inhibitors |
| JP5383483B2 (ja) * | 2007-04-24 | 2014-01-08 | 塩野義製薬株式会社 | アルツハイマー症治療用医薬組成物 |
| CA2711655C (en) * | 2008-01-18 | 2013-03-05 | Eisai R&D Management Co., Ltd. | Condensed aminodihydrothiazine derivative |
| AU2009239535A1 (en) | 2008-04-22 | 2009-10-29 | Schering Corporation | Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| KR20110076965A (ko) | 2008-09-30 | 2011-07-06 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신규한 축합 아미노 디하이드로티아진 유도체 |
| AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| GB0912778D0 (en) * | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
| US7964594B1 (en) * | 2009-12-10 | 2011-06-21 | Hoffmann-La Roche Inc. | Amino oxazine derivatives |
| US20120245155A1 (en) | 2009-12-11 | 2012-09-27 | Shionogi & Co., Ltd. | Fused heterocyclic compound having amino group |
| US8598161B2 (en) | 2011-05-24 | 2013-12-03 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| EP2751116B1 (en) | 2011-08-31 | 2016-10-12 | Pfizer Inc | Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds |
-
2013
- 2013-03-21 JO JOP/2013/0080A patent/JO3143B1/ar active
- 2013-03-22 AR ARP130100947A patent/AR090474A1/es unknown
- 2013-03-22 TW TW102110358A patent/TWI572610B/zh not_active IP Right Cessation
- 2013-03-27 JP JP2015504623A patent/JP6067099B2/ja not_active Expired - Fee Related
- 2013-03-27 ES ES13715556.0T patent/ES2584827T3/es active Active
- 2013-03-27 HU HUE13715556A patent/HUE030097T2/en unknown
- 2013-03-27 US US13/851,116 patent/US8629270B2/en not_active Expired - Fee Related
- 2013-03-27 SI SI201330189A patent/SI2836495T1/sl unknown
- 2013-03-27 WO PCT/US2013/033959 patent/WO2013151832A1/en active Application Filing
- 2013-03-27 CA CA2866201A patent/CA2866201C/en not_active Expired - Fee Related
- 2013-03-27 RS RS20160505A patent/RS54899B1/sr unknown
- 2013-03-27 PL PL13715556.0T patent/PL2836495T3/pl unknown
- 2013-03-27 PT PT137155560T patent/PT2836495T/pt unknown
- 2013-03-27 CN CN201380017730.6A patent/CN104185635B/zh not_active Expired - Fee Related
- 2013-03-27 EP EP13715556.0A patent/EP2836495B1/en active Active
- 2013-03-27 ME MEP-2016-117A patent/ME02404B/me unknown
- 2013-03-27 DK DK13715556.0T patent/DK2836495T3/en active
- 2013-12-04 US US14/096,443 patent/US8772282B2/en not_active Expired - Fee Related
-
2014
- 2014-05-22 US US14/284,452 patent/US8889856B2/en not_active Expired - Fee Related
-
2016
- 2016-06-14 HR HRP20160674TT patent/HRP20160674T1/hr unknown
- 2016-06-24 CY CY20161100566T patent/CY1117688T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015512445A (ja) | 2015-04-27 |
| CN104185635A (zh) | 2014-12-03 |
| HRP20160674T1 (hr) | 2016-07-15 |
| ME02404B (me) | 2016-09-20 |
| US20140256933A1 (en) | 2014-09-11 |
| CY1117688T1 (el) | 2017-05-17 |
| EP2836495B1 (en) | 2016-05-18 |
| EP2836495A1 (en) | 2015-02-18 |
| HUE030097T2 (en) | 2017-04-28 |
| PT2836495T (pt) | 2016-07-18 |
| US8629270B2 (en) | 2014-01-14 |
| RS54899B1 (sr) | 2016-10-31 |
| PL2836495T3 (pl) | 2016-11-30 |
| JP6067099B2 (ja) | 2017-01-25 |
| US20130261111A1 (en) | 2013-10-03 |
| US20140094454A1 (en) | 2014-04-03 |
| ES2584827T3 (es) | 2016-09-29 |
| WO2013151832A1 (en) | 2013-10-10 |
| TW201400491A (zh) | 2014-01-01 |
| CN104185635B (zh) | 2016-03-09 |
| JO3143B1 (ar) | 2017-09-20 |
| TWI572610B (zh) | 2017-03-01 |
| CA2866201C (en) | 2016-09-20 |
| SI2836495T1 (sl) | 2016-06-30 |
| DK2836495T3 (en) | 2016-08-15 |
| US8889856B2 (en) | 2014-11-18 |
| CA2866201A1 (en) | 2013-10-10 |
| US8772282B2 (en) | 2014-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR090474A1 (es) | Compuestos de tetrahidropirrolotiazina | |
| AR094918A1 (es) | Compuestos de tetrahidropirrolotiazina como inhibidores de bace | |
| AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
| AR106252A2 (es) | Compuestos de pirrolo[2,3-d]pirimidina | |
| AR090589A1 (es) | INHIBIDORES DE b-LACTAMASA ISOXAZOL | |
| RS54873B1 (sr) | Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| AR090590A1 (es) | COMPUESTOS 1,3,4-OXADIAZOL Y 1,3,4-TIADIAZOL COMO INHIBIDORES DE b-LACTAMASA | |
| AR092269A1 (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| EA201790661A3 (ru) | Ингибиторы вируса гепатита c | |
| AR091271A1 (es) | Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| AR090121A1 (es) | Compuestos de oxazolidin-2-ona y usos de los mismos | |
| AR093759A1 (es) | Dihidropiridona p1 como inhibidores del factor xia | |
| AR094812A1 (es) | Derivado de piridina monocíclico como inhibidor del fgfr | |
| AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
| AR094959A1 (es) | Compuestos de imidazo piridina | |
| AR091770A1 (es) | Indolcarbonitrilos moduladores selectivos de receptores androgenicos | |
| AR097866A1 (es) | Derivados de 4-azaindol | |
| AR089771A1 (es) | Derivados de bencil sulfonamida utiles como inhibidores de mogat-2 | |
| AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
| CO6480931A2 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas. | |
| TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
| AR101696A1 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| DOP2016000009A (es) | Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |